Nexalin Technology NXL
NASDAQ NXL
$4.85 -0.20 (-3.96%)
As of: Sep 10, 2026 · 3:47 PM EDT

Nexalin Technology (NXL) Cash & Current Investments (2021 - 2026)

Nexalin Technology (NXL) posted Cash & Current Investments of $1.0 million for Q2 2026, down 66.51% on a QoQ basis from $3.0 million in Q1 2026, and down 90.63% year-over-year from $10.7 million in Q2 2025.

Analysis

Nexalin Technology (NXL) Cash & Current Investments (2021 - 2026) Analysis & Trends

Nexalin Technology has reported Cash & Current Investments for 6 years, with the latest figure at $1.0 million in Q2 2026.

  • On a quarterly basis, Cash & Current Investments fell 90.63% year-over-year to $1.0 million in Q2 2026; TTM through Jun 2026 was $1.0 million, a 90.63% decrease from a year earlier, with the FY2025 full-year figure at $6.1 million, up 5.61% from the prior year.
  • Cash & Current Investments was $1.0 million for Q2 2026 at Nexalin Technology, down from $3.0 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $13.7 million in Q4 2022, with the low at $848796.0 in Q2 2024.
  • Average Cash & Current Investments over 5 years is $6.4 million, with a median of $6.6 million recorded in 2023.
  • The sharpest annual moves came in 2022 and 2026: Cash & Current Investments soared 1964.5% in 2022, then slumped 90.63% in 2026.
  • Over 5 years, Cash & Current Investments stood at $13.7 million in 2022, then slumped by 65.33% to $4.7 million in 2023, then gained by 22.69% to $5.8 million in 2024, then grew by 5.61% to $6.1 million in 2025, then tumbled by 83.62% to $1.0 million in 2026.
  • The last three Cash & Current Investments figures came in at $1.0 million (Q2 2026), $3.0 million (Q1 2026), and $6.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Abbott Laboratories 179.84 Bn 174.23 Bn 7.27 Bn 5.60 Bn
2 Intuitive Surgical 128.02 Bn 122.81 Bn 1.96 Bn 5.22 Bn
3 Medtronic 117.28 Bn 108.46 Bn 6.34 Bn 8.82 Bn
4 Stryker 103.92 Bn 100.44 Bn 4.50 Bn 3.48 Bn
5 Boston Scientific 63.51 Bn 62.97 Bn 3.85 Bn 539.00 Mn
6 Edwards Lifesciences 49.96 Bn 45.70 Bn 1.35 Bn 4.25 Bn
7 Alcon 32.86 Bn 31.40 Bn 1.68 Bn 1.46 Bn
8 Dexcom 32.25 Bn 30.30 Bn 830.00 Mn 1.95 Bn
9 Steris 20.74 Bn 20.26 Bn 684.20 Mn 482.30 Mn
10 Nexalin Technology 3.42 Mn 2.41 Mn 8,897.00 1.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.00 Mn
Mar 31, 2026 3.00 Mn
Dec 31, 2025 6.14 Mn
Sep 30, 2025 7.53 Mn
Jun 30, 2025 10.72 Mn
Mar 31, 2025 2.86 Mn
Dec 31, 2024 5.81 Mn
Sep 30, 2024 9.02 Mn
Jun 30, 2024 848,796.00
Mar 31, 2024 3.20 Mn
Dec 31, 2023 4.74 Mn
Sep 30, 2023 7.15 Mn
Jun 30, 2023 8.93 Mn
Mar 31, 2023 10.60 Mn
Dec 31, 2022 13.66 Mn
Sep 30, 2022 7.86 Mn
Dec 31, 2021 661,778.00